Compugen Ltd. logo

Compugen Ltd.

NASDAQ:CGEN

Overview | Financials
Company Name Compugen Ltd.
Symbol CGEN
Currency USD
Price 1.9
Market Cap 170,119,160
Dividend Yield 0%
52-week-range 0.53 - 3.03
Industry Biotechnology
Sector Healthcare
CEO Dr. Anat Cohen-Dayag Ph.D.
Website https://cgen.com

An error occurred while fetching data.

About Compugen Ltd.

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a

Related Stocks

NeuroPace, Inc. logo

NeuroPace, Inc.

NPCE

6.82 USD

Quipt Home Medical Corp. logo

Quipt Home Medical Corp.

QIPT

2.88 USD

Savara Inc. logo

Savara Inc.

SVRA

4.44 USD

Clene Inc. logo

Clene Inc.

CLNN

5.02 USD

Fennec Pharmaceuticals Inc. logo

Fennec Pharmaceuticals Inc.

FENC

5.22 USD

Vor Biopharma Inc. logo

Vor Biopharma Inc.

VOR

0.934 USD

High Tide Inc. logo

High Tide Inc.

HITI

2.11 USD

Meihua International Medical Technologies Co., Ltd. logo

Meihua International Medical Technologies Co., Ltd.

MHUA

1.03 USD

Financials

Numbers are in millions USD

Numbers are in millions USD